INTRODUCTION
Tumour burden has profound effects on lipid metabolism. These include decreases in whole-body lipid oxidation rates (Costa et al., 1976) , lipoprotein lipase activity and the rate of lipogenesis in white adipose tissue (Thompson et al., 1981; Lanza-Jacoby et al., 1984) , and an increase in plasma triacylglycerols (Lanza-Jacoby et al., 1984) . Recently the tissue-specific effects of malignant tumour (Walker-256 carcinosarcoma) burden on mammary-gland and adipose-tissue lipid metabolism during lactation and after premature removal of the pups have been described . The tumour was found to exert its deleterious effects mainly during periods of rapid transition in metabolism (parturition and establishment of lactation; weaning) Williamson et al., 1988) . These effects include decreased ["4C] lipid accumulation in plasma together with hypertriglyceridaemia, and decreased lipogenesis in white and brown adipose tissue in litterremoved rats, effects not seen during tumour growth in established lactation . Tumour growth before parturition inhibits lactation post partum . Some of the effects of tumour burden in rats can be mimicked by macrophage cytokines, notably suppression of lipoprotein lipase activity in adipose tissue by recombinant-derived tumour necrosis factor a (TNFa, cachectin) both in vitro (Price et at., 1986) and in vivo (Semb et al., 1987) , and this had led to the suggestion that it may be the causative agent of tumour cachexia (Beutler & Cerami, 1987) . In a human study, half the patients with active cancer had increased serum TNFa (Balkwill et al., 1987) . Much of the present information on the effects of TNFa on lipid metabolism comes from studies on cultured cell lines rather than in vivo (see Moldawer et al., 1988) . In the present study we have investigated the effect of recombinant-derived human TNFa on lipid metabolism in vivo during lactation and on litter removal to examine whether this cytokine can mimic the previously reported effects of tumour growth Parametrial-adipose-tissue, mammary-gland and heart lipoprotein lipase activities were determined on acetone/diethyl ether-dried powders of the tissues as described previously Williamson, 1986) . Profound gastrointestinal-tract dysfunction, with even macroscopic haemorrhagic necrosis of the small bowel, has been reported in virgin animals in response to high doses of TNFa (Tracey et al., 1986) . This effect may account for many of the metabolic derangements noted in previously reported studies, as recorded food intake or even gastric gavage may be an unreliable index of metabolic substrate availability to the animal in vivo. In our experiments (0.6 mg of TNFa/kg body wt.) the bowel appeared macroscopically normal and no rats died (see also Sun & Hsueh, 1988 .
1988
Tumour necrosis factor and lipid metabolism (Table 2 ). Hyperlipaemia has been noted previously in tumour-bearing animals (Lanza-Jacoby et al., 1984; . A possible mechanism in tumour-bearing rats is the suppression of adiposetissue lipoprotein lipase activity (Thompson et al., 1981;  Vol. 256 Lanza-Jacoby et al., 1984; , and this was observed in the parametrial adipose tissue of virgin and litter-removed rats treated with TNFa (Table 2) ; this activity is physiologically low in the adipose-tissue activity is significantly depressed (Evans & 1987) and therefore was not measured. However, lipoprotein lipase activity was decreased in lactating mammary gland, a novel finding indicating a relatively nontissue-specific effect of the cytokine (Table 2) . Tumour burden has been shown not to suppress lipoprotein lipase activity in lactating mammary gland at a time when adipose tissue activity is significantly depressed , suggesting that TNFo has additional effects not seen during tumour growth ). However, some tissue specificity of TNFa action appears to exist, as lipoprotein lipase activity in heart was not suppressed by this cytokine in any experimental group (Table 2) . It has recently been reported that TNFa has no short-term effect on the activity of lipoprotein lipase in the perfused heart (Hfilsmann et al., 1988) .
Thus TNFo has a wide range of actions on lipid metabolism, including decreased lipid absorption and decreased lipid assimilation by lactating mammary gland, effects not observed in response to tumour growth in rats . The decreased absorption may be due to a delay in gastric emptying (Patton et al., 1987) . The hyperlipaemia occurring in response to TNFoc administration (despite a decrease in lipid absorption) in the present experiments may be explained by the decrease in lipoprotein lipase activity in mammary gland (lactating rats) or adipose tissue (virgin and litter-removed rats); however, a contribution from increased lipolysis in adipose tissue in these states cannot be ruled out. Stimulation of lipolysis by TNFa in vitro has been demonstrated (Patton et al., 1986; Kawakami et al., 1987 ; but see Price et al., 1986; Rofe et al., 1987) .
We thank Mrs. Vera Ilic for skilled assistance and Mrs. 
